prof. dr. ir. Peter Van Eenoo
Show
Sort by
-
Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry Comparison between liquid-liquid extraction and direct injection
-
Quantification of testosterone undecanoate in human hair by liquid chromatography-tandem mass spectrometry
-
Stability of selected chlorinated thiazide diuretics
-
The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione
-
Detection and characterization of a new metabolite of 17 α-methyltestosterone
-
uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study
-
Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry
-
Development and validation of a quantitative gas chromatography-mass spectrometry method for the detection of endogenous androgens in mouse urine
-
Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry
-
Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation
-
Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites
-
Results of several (small) research projects at DoCoLab in 2007
-
Stability studies of thiazide diuretics
-
Validation of the metabolism of steroids in uPA+/+-SCID mice with humanized liver
-
Direct quantification of steroid glucuronides by liquid chromatography tandem mass spectrometry
-
General guidelines for the CID fragmentation of 3-keto-anabolic steroids
-
Implementation of DRS in doping control
-
Direct quantification of steroid glucuronides in human urine by liquid chromatography-electrospray tandem mass spectrometry
-
Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry
-
Detection and characterization of anabolic steroids in doping analysis by LC-MS
-
Detection of doping agents by LC-MC and LC-MC-MC
-
Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry
-
Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis
-
Results of stability studies with doping agents in urine
-
Detection of selected stimulants as contaminants in solid nutritional supplements by liquid chromatography-mass spectrometry
-
Presence of endogenous interferences in the urinary detection of selected anabolic steroids by liquid chromatography/electrospray tandem mass spectrometry
-
Comprehensive screening method for the qualitative detection of narcotics and stimulants using single step derivatisation
-
Development and validation of a qualitative screening method for the detection of exogenous anabolic steroids in urine by liquid chromatography-tandem mass spectrometry
-
Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry
-
Results of several (small) research projects at DoCoLab in 2005
-
Comprehensive screening method for the detection of narcotics and stimulants using single-step derivatisation
-
Detection of 19-norandrosterone after ingestion of the oral contraceptives norethisterone acetate and lynestrenol and ethylestrenol
-
Quantitative LC-MS determination of strychnine in urine after ingestion of a Strychnos nux-vomica preparation and its consequences in doping control
-
Nutritional supplements: prevalence of use and contamination with doping agents
-
Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry
-
Detection of hydroxyethylstarch (HES) in human urine by liquid chromatography-mass spectrometry
(2006) JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 834(1-2). p.217-220 -
New urinary EPO drug testing method using two-dimensional gel electrophoresis
-
Metabolism and excretion of anabolic steroids in doping control - New steroids and new insights
-
Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry
-
Improved clean-up for the detection of hydroxyethylstarch (HES)
-
Extension of an existing screening method for diuretics with beta-blocking agents
-
Metabolism, excretion and detection of androst-4ene-3,6,17-trione
-
Detection of androst-4-ene-3,6,17-trione (6-OXO (R)) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis
-
Quantitative analysis of androst-4-ene-3,6,17-trione and metabolites in human urine after the administration of a food supplement by liquid chromatography/ion trap-mass spectrometry
-
Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography mass spectrometry with scan-to-scan polarity switching
-
chromatographic and mass spectrometric criteria in doping and related areas
-
Stability Studies of Selected Doping Substances in Methanolic Solution
-
Norandrosterone and noretiocholanoone concentration before and after submaximal standardized exercise
-
Criteria in chromatography and mass spectrometry - a comparison between regulations in the field of residue and doping analysis
-
Excretion studies with salbutamol and salmeterol after inhalation